TG4001 – Transgene

Transgene to present Phase 1b/2 trial results of TG4001 in combination with avelumab in advanced HPV-positive cancers at ESMO IO 2020

20201203 - TG4001 mini oral prez ESMO IO EN

By nh|2020-12-03T18:24:25+01:00December 3rd, 2020|Press release, TG4001, TG4001|Comments Off

20201109 - TG4001+avelumab presentation poster SITC - EN

By nh|2020-11-09T16:44:54+01:00November 9th, 2020|Press release, TG4001, TG4001|Comments Off

20201027 - TG4001+avelumab abstract data SITC - EN

By @CcR34Tg|2020-10-26T18:53:22+01:00October 27th, 2020|Press release, TG4001, TG4001|Comments Off

20201019 TG4001+avelumab SITC - EN

By nh|2020-10-16T16:20:03+02:00October 19th, 2020|Press release, TG4001, TG4001|Comments Off

CP TG4001+avelumab EN - Vdef-

By nh|2020-07-22T16:30:04+02:00July 22nd, 2020|Press release, TG4001, TG4001|Comments Off

20190930 PR TG4001 ESMO EN

By nh|2019-11-05T09:54:59+01:00September 30th, 2019|Press release, TG4001, TG4001|Comments Off

Christophe Le Tourneau et al. ESMO 2019 Download the poster [...]

By Lucie Larguier|2020-07-22T14:04:14+02:00September 30th, 2019|Publication, TG4001, TG4001|Comments Off

Diane M. Harper, et al. Gynecologic Oncology, April 2019 - [...]

By nh|2020-07-22T14:05:49+02:00April 18th, 2019|Publication, TG4001, TG4001|Comments Off